Form 4: Cytokinetics Director Robert Harrington Sells 450 Shares of Common Stock

Director Robert Arthur Harrington sold 450 shares of Cytokinetics Inc. common stock at a price of $39.43 on April 3, 2025.

Summary

• On April 3, 2025, Robert Arthur Harrington, a director of Cytokinetics Inc., sold 450 shares of the company's common stock.
• The sale was executed at a price of $39.43 per share.
• Following the transaction, Harrington directly owns 14,658 shares of Cytokinetics Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a routine disclosure of a transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock, and these transactions are closely monitored by regulators and investors.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's reasons for selling.

Key Dates

Keywords

Form 4, CYTK, Cytokinetics Inc., Robert Harrington, Stock Sale, Director